916085--2/28/2008--HEALTH_NET_INC

related topics
{regulation, government, change}
{system, service, information}
{debt, indebtedness, cash}
{financial, litigation, operation}
{operation, natural, condition}
{loss, insurance, financial}
{tax, income, asset}
{acquisition, growth, future}
{product, market, service}
{loan, real, estate}
{condition, economic, financial}
{personnel, key, retain}
{cost, regulation, environmental}
{stock, price, share}
{cost, contract, operation}
Our profitability will depend, in part, on our ability to accurately predict and control health care costs. We face competitive pressure to contain premium prices. Our inability to estimate and maintain appropriate levels of reserves for claims may adversely affect our business, financial condition or results of operations. Our businesses are subject to significant government regulation, which increases our cost of doing business and could adversely affect our ability to grow our businesses. Our efforts to capitalize on Medicare business opportunities could prove to be unsuccessful. A significant reduction in revenues from the government programs in which we participate could have an adverse effect on our business, financial condition or results of operations. We may experience losses as a result of the regional concentration of our business. Proposed federal and state legislation and regulations affecting the managed health care industry could adversely affect us. Regulatory activities and litigation relating to the rescission of coverage, if resolved unfavorably, could adversely affect us. Federal and state audits, review and investigations of us and our subsidiaries could have a material adverse effect on our operations. If we are unable to maintain good relations with the physicians, hospitals and other providers that we contract with, our profitability could be adversely affected. We face risks related to litigation, which, if resolved unfavorably, could result in substantial penalties and/or monetary damages, including punitive damages. In addition, we incur material expenses in the defense of litigation and our results of operations or financial condition could be adversely affected if we fail to accurately project litigation expenses. Our forecasts and other forward-looking statements are based on a variety of assumptions that are subject to significant uncertainties. Our performance may not be consistent with these forecasts and forward-looking statements. The markets in which we do business are highly competitive. If we do not design and price our products competitively, our membership and profitability could decline. We have historically experienced significant turnover in senior management and are in the process of reorganizing our management structure. If we are unable to manage the succession of our key executives, it could adversely affect our business. We have a material amount of indebtedness and may incur additional indebtedness, or need to refinance existing indebtedness, in the future, which may adversely affect our operations. We are a holding company and a substantial amount of our cash flow is generated by our subsidiaries. Our regulated subsidiaries are subject to restrictions on the payment of dividends and maintenance of minimum levels of capital. Our revolving credit facility and our financing facility contain restrictive covenants that could limit our ability to pursue our business strategies. If we fail to effectively maintain our management information systems, it could adversely affect our business. We are subject to risks associated with outsourcing services and functions to third parties. We must comply with restrictions on patient privacy and information security, including taking steps to ensure compliance by our business associates with HIPAA. Negative publicity regarding the managed health care industry could adversely affect our ability to market and sell our products and services. If we are unable to manage our general and administrative expenses, our business, financial condition or results of operations could be harmed. If we are required to publicly disclose information regarding our reimbursement rates and preferred drug lists for our programs, it could have a material adverse effect on our business. Changes in the value of our investment assets could have a negative effect on our results of operations and stockholders equity. We depend, in part, on independent brokers and sales agents to market our products and services, and recent regulatory investigations have focused on certain brokerage practices, including broker compensation arrangements and bid quoting practices. The market price of our common stock is volatile. Large-scale public health epidemics and/or terrorist activity could cause us to incur unexpected health care and other costs and could materially and adversely affect our business, financial condition and results of operations. Natural disasters, including earthquakes, fires and floods, could severely damage or interrupt our systems and operations and result in an adverse effect on our business, financial condition or results of operations. Current unfavorable economic conditions could negatively affect our revenues and profitability.

Full 10-K form ▸

related documents
916085--2/27/2009--HEALTH_NET_INC
916085--3/1/2007--HEALTH_NET_INC
916085--2/13/2006--HEALTH_NET_INC
1156039--2/23/2006--WELLPOINT_INC
1046568--3/6/2006--CAREER_EDUCATION_CORP
1047335--3/16/2007--NATIONAL_HEALTHCARE_CORP
1063561--12/28/2006--PROSPECT_MEDICAL_HOLDINGS_INC
1141103--3/15/2007--CROSS_COUNTRY_HEALTHCARE_INC
1141103--3/9/2006--CROSS_COUNTRY_HEALTHCARE_INC
809398--3/16/2006--FIDELITY_NATIONAL_FINANCIAL_INC_/DE/
1170650--2/24/2009--MEDCO_HEALTH_SOLUTIONS_INC
33619--12/21/2007--ESTERLINE_TECHNOLOGIES_CORP
1170650--2/19/2008--MEDCO_HEALTH_SOLUTIONS_INC
33619--12/24/2008--ESTERLINE_TECHNOLOGIES_CORP
1145238--9/27/2006--INSIGHT_HEALTH_SERVICES_HOLDINGS_CORP
893430--12/12/2006--PEDIATRIC_SERVICES_OF_AMERICA_INC
803352--9/9/2008--CONTINUCARE_CORP
33619--1/8/2007--ESTERLINE_TECHNOLOGIES_CORP
829608--2/25/2010--PSYCHIATRIC_SOLUTIONS_INC
1170650--2/23/2010--MEDCO_HEALTH_SOLUTIONS_INC
1054833--2/27/2009--COVENTRY_HEALTH_CARE_INC
1139463--12/15/2008--MEDCATH_CORP
1139463--12/14/2006--MEDCATH_CORP
920148--2/26/2009--LABORATORY_CORP_OF_AMERICA_HOLDINGS
1007330--3/23/2007--PRG_SCHULTZ_INTERNATIONAL_INC
1035688--3/20/2006--SELECT_MEDICAL_CORP
1320414--3/30/2007--SELECT_MEDICAL_HOLDINGS_CORP
19584--2/26/2010--CHEMED_CORP
33619--12/22/2009--ESTERLINE_TECHNOLOGIES_CORP
1123360--8/4/2006--GLOBAL_PAYMENTS_INC